Published in J Endourol on December 01, 2006
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology (2005) 2.71
Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. J Urol (2012) 2.42
The use of a novel reverse thermosensitive polymer to prevent ureteral stone retropulsion during intracorporeal lithotripsy: a randomized, controlled trial. J Urol (2010) 2.20
The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement. Eur Urol (2007) 2.03
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol (2009) 1.92
uPM3, a new molecular urine test for the detection of prostate cancer. Urology (2004) 1.91
Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer (2004) 1.90
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer (2006) 1.75
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis. J Urol (2012) 1.65
Training future surgeons for management roles: the resident-surgeon-manager conference. Arch Surg (2012) 1.60
Impact of radiological technologists on the outcome of shock wave lithotripsy. Urology (2011) 1.59
Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol (2009) 1.39
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. Radiology (2003) 1.33
Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. Radiology (2007) 1.29
Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int (2008) 1.23
Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol (2006) 1.18
Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin Cancer Res (2009) 1.17
Modeling a lethal prostate cancer variant with small-cell carcinoma features. Clin Cancer Res (2011) 1.15
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. Neoplasia (2010) 1.14
PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications. Genes Chromosomes Cancer (2011) 1.11
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. J Urol (2002) 1.11
The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases. Cancer (2010) 1.10
Canadian guidelines for the management of benign prostatic hyperplasia. Can J Urol (2005) 1.10
Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome. BJU Int (2009) 1.07
Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer. Histopathology (2012) 1.06
Finasteride monotherapy maintains stable lower urinary tract symptoms in men with benign prostatic hyperplasia following cessation of alpha blockers. Can Urol Assoc J (2008) 1.02
Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol (2005) 1.01
Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance. Cancer (2008) 1.01
Artificial ureters in renal transplantation. Urology (2005) 0.99
Kidney cancer, version 2.2014. J Natl Compr Canc Netw (2014) 0.98
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction. BJU Int (2005) 0.97
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol (2012) 0.96
Prioritizing genes associated with prostate cancer development. BMC Cancer (2010) 0.94
Factors determining stone-free rate in shock wave lithotripsy using standard focus of Storz Modulith SLX-F2 lithotripter. Urology (2011) 0.94
Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients. Photochem Photobiol (2005) 0.94
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. BJU Int (2008) 0.94
Plasmacytoid urothelial carcinoma of the bladder: a case report. Cases J (2009) 0.93
NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model. Clin Cancer Res (2007) 0.93
Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study. Curr Med Res Opin (2007) 0.91
Sonographic diagnosis of a ruptured intratesticular pseudoaneurysm secondary to orchitis. AJR Am J Roentgenol (2007) 0.91
Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer. Cancer Res (2005) 0.89
Factors determining fluoroscopy time during ureteroscopy. J Endourol (2011) 0.89
Determinants of performance on the Transfer Task of the Basic Laparoscopic Urologic Surgery (BLUS(©)) curriculum administered at objective structured clinical examinations. J Endourol (2013) 0.88
Measuring surgical recovery: the study of laparoscopic live donor nephrectomy. Am J Transplant (2005) 0.88
"First, do no harm": monitoring outcomes during the transition from open to laparoscopic live donor nephrectomy in a Canadian centre. Can J Surg (2008) 0.88
Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol (2012) 0.88
Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms. J Urol (2006) 0.88
Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily. Urology (2005) 0.87
Validation of the da Vinci Surgical Skill Simulator across three surgical disciplines: A pilot study. Can Urol Assoc J (2013) 0.87
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia. Urology (2003) 0.87
Testicular Cancer, Version 2.2015. J Natl Compr Canc Netw (2015) 0.86
Digital nephroscopy: the next step. J Endourol (2008) 0.85
Randomized controlled trial of virtual reality and hybrid simulation for robotic surgical training. BJU Int (2011) 0.84
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol (2010) 0.84
Hybrid augmented reality simulator: preliminary construct validation of laparoscopic smoothness in a urology residency program. J Urol (2008) 0.84
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH. BJU Int (2005) 0.83
Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model. J Urol (2013) 0.83
Robot-assisted laparoscopic partial nephrectomy: Early single Canadian institution experience. Can Urol Assoc J (2013) 0.83
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression. Transl Oncol (2012) 0.82
Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy. Cell Tissue Bank (2011) 0.82
Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis. BJU Int (2008) 0.82
Construct validity of the LapSim virtual reality laparoscopic simulator within a urology residency program. Can Urol Assoc J (2012) 0.81
Effect of the potassium channel opener WAY-133537 on the overactive bladder of spinalized rats. Neurourol Urodyn (2006) 0.81
Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study. World J Surg Oncol (2013) 0.80
Enhancer of zeste homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma: a comparative study and review of the literature. Arch Pathol Lab Med (2013) 0.79
Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate. J Urol (2011) 0.78
Impact of the type of ultrasound probe on prostate cancer detection rate and characterization in patients undergoing MRI-targeted prostate biopsies using cognitive fusion. World J Urol (2013) 0.77
A modified access technique for retroperitoneoscopic renal surgery in children. J Urol (2003) 0.77
Role of 5-HT receptors in treatment of overactive bladder. Drugs Today (Barc) (2003) 0.77
Urinary bladder hyperreflexia: a rat animal model. Neurourol Urodyn (2003) 0.77
Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis. Can Urol Assoc J (2013) 0.77
Percutaneous radiofrequency ablation of small renal tumors using CT-guidance: a review and its current role. Urol J (2012) 0.76
Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin. Can J Urol (2005) 0.76
The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme? Can Urol Assoc J (2009) 0.76
Systemic therapy for sarcomatoid renal cell carcinoma. Expert Rev Anticancer Ther (2011) 0.76
Feasibility of simultaneous testicular microdissection for sperm retrieval and ipsilateral testicular tumor resection in azoospermic men. J Androl (2004) 0.76
Postural control during laparoscopic surgical tasks. Am J Surg (2007) 0.75
[¹⁸F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case. J Clin Oncol (2012) 0.75
Vardenafil in patients with erectile dysfunction: achieving treatment optimization. J Androl (2005) 0.75
Editorial comment. Urology (2010) 0.75
Laparoscopic live donor nephrectomy: the pediatric recipient in a dual-site program. Pediatr Transplant (2007) 0.75
Pyelocystostomy for treatment of recurrent nephrolithiasis and ureteropelvic junction obstruction in a pelvic kidney. Can J Urol (2016) 0.75
Diagnostic and prognostic role of immunohistochemical expression of napsin-A aspartic peptidase in clear cell and papillary renal cell carcinoma: a study including 233 primary and metastatic cases. Appl Immunohistochem Mol Morphol (2014) 0.75
Visceral organ-to-percutaneous tract distance is shorter when patients are placed in the prone position on bolsters compared with the supine position. J Endourol (2011) 0.75
Holmium laser enucleation of prostate in patients with prostate size </=60 cm3. Urology (2008) 0.75